Topic resource collection
Approved comparison material connected to this topic.
3 resourcesRead both sides
Phase I Healthy volunteers or target condition 8–20 visits over 6–12 weeks 6–12 weeks Safety: AEs, vitals, ECG, pharmacokinetics (serial blood draws) $4,000–$15,000 Intensive monitoring requires time flexibility; highest per-visi…
Preclinical Safety & mechanism in animals Animal models, in-vitro 3–6 years ~5–10% file IND Foundation. Poor preclinical data guarantees Phase I failure Phase I Safety & pharmacokinetics 20–80 healthy volunteers or patients 12–18…
Oral bioavailability requires the peptide to survive gastric acid and proteolytic enzymes, cross the intestinal epithelium, and reach systemic circulation at therapeutic concentrations. Fewer than 1% of unmodified peptides achiev…